In Silico Prediction of Hub Genes Involved in Diabetic Kidney and COVID-19 Related Disease by Differential Gene Expression and Interactome Analysis

Genes (Basel). 2022 Dec 19;13(12):2412. doi: 10.3390/genes13122412.

Abstract

Diabetic kidney disease (DKD) is a frequently chronic kidney pathology derived from diabetes comorbidity. This condition has irreversible damage and its risk factor increases with SARS-CoV-2 infection. The prognostic outcome for diabetic patients with COVID-19 is dismal, even with intensive medical treatment. However, there is still scarce information on critical genes involved in the pathophysiological impact of COVID-19 on DKD. Herein, we characterize differential expression gene (DEG) profiles and determine hub genes undergoing transcriptional reprogramming in both disease conditions. Out of 995 DEGs, we identified 42 shared with COVID-19 pathways. Enrichment analysis elucidated that they are significantly induced with implications for immune and inflammatory responses. By performing a protein-protein interaction (PPI) network and applying topological methods, we determine the following five hub genes: STAT1, IRF7, ISG15, MX1 and OAS1. Then, by network deconvolution, we determine their co-expressed gene modules. Moreover, we validate the conservancy of their upregulation using the Coronascape database (DB). Finally, tissue-specific regulation of the five predictive hub genes indicates that OAS1 and MX1 expression levels are lower in healthy kidney tissue. Altogether, our results suggest that these genes could play an essential role in developing severe outcomes of COVID-19 in DKD patients.

Keywords: COVID-19; diabetic kidney disease; hub genes; in silico analysis; metabolic pathways; potential therapeutic.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • COVID-19* / genetics
  • Diabetes Mellitus*
  • Diabetic Nephropathies* / genetics
  • Gene Expression
  • Humans
  • Kidney
  • SARS-CoV-2

Grants and funding

This research was funded by CONACYT-FOP16-2021-01 (319930) and PROFAPI 2022 (PRO_A2_019) projects. K.A.P (CVU:227919) received financial support from CONACyT and is a current holder of a fellowship from the Fulbright García-Robles foundation.